Substance P affects growth factors in pseudomonas aeruginosa-infected mouse cornea

Cornea

Volumn 31, Issue 10, 2012, Pages 1176-1188

  Foldenauer, Megan E B ^a   McClellan, Sharon A ^a   Barrett, Ronald P ^a   Zhang, Yunfan ^a   Hazlett, Linda D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bacteria; cornea; growth factors; mice; SP

Indexed keywords

CASPASE 3; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; INTERLEUKIN 1BETA; KERATINOCYTE GROWTH FACTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHOSPHATE BUFFERED SALINE; PROTEIN BCL 2; SCATTER FACTOR; SUBSTANCE P; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL COUNT; CONTROLLED STUDY; CORNEA; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; IMMUNOHISTOCHEMISTRY; KERATITIS; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; WOUND HEALING;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL COUNT; CORNEAL ULCER; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE INFECTIONS, BACTERIAL; FEMALE; GENE EXPRESSION REGULATION; INJECTIONS, INTRAPERITONEAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; NEUROTRANSMITTER AGENTS; PSEUDOMONAS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBSTANCE P; WOUND HEALING;

EID: 84866251252     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31824d6ffd     Document Type: Article

References (59)

1. Pachigolla G, Blomquist P, Cavanagh HD. Microbial keratitis pathogens and antibiotic susceptibilities: a 5-year review of cases at an urban county hospital in north Texas. Eye Contact Lens. 2007;33:45-49. (Pubitemid 46114828)
2. Wilhelmus KR. Bacterial keratitis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St. Louis: Mosby; 1995: 970-1031.
3. Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2000;2:1051-1060. (Pubitemid 30664219)
4. Hazlett LD, McClellan S, Kwon B, et al. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive. Invest Ophthalmol Vis Sci. 2000;41:805-810. (Pubitemid 30158892)
5. McClellan SA, Huang X, Barrett RP, et al. Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice. J Immunol. 2003;170:5219-5227. (Pubitemid 36554755)
6. Kernacki KA, Barrett RP, Hobden JA, et al. Macrophage inflammatory protein-2 is a mediator of polymorphonuclear neutrophil influx in ocular bacterial infection. J Immunol. 2000;164:1037-1045. (Pubitemid 30043732)
7. Kwon B, Hazlett LD. Association of CD4+ T cell-dependent keratitis with genetic susceptibility to Pseudomonas aeruginosa ocular infection. J Immunol. 1997;159:6283-6290. (Pubitemid 127471571)
8. Lighvani S, Huang X, Trivedi PP, et al. Substance P regulates natural killer cell interferon-gamma production and resistance to Pseudomonas aeruginosa infection. Eur J Immunol. 2005;35:1567-1575. (Pubitemid 40691437)
9. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. J Immunol. 2008;181:3733-3739.
10. Mills CD, Kincaid K, Alt JM, et al. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000;164:6166-6173. (Pubitemid 30408793)
11. Joshi AD, Raymond T, Coelho AL, et al. A systemic granulomatous response to Schistosoma mansoni eggs alters responsiveness of bone-marrow-derived macrophages to Toll-like receptor agonists. J Leukoc Biol. 2008;83:314-324. (Pubitemid 351225612)
12. Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23:549-555. (Pubitemid 35223554)
13. Hazlett LD, McClellan SA, Barrett RP, et al. IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci. 2010;51:1524-1532.
14. Zhang Y, Berger A, Milne CD, et al. Tachykinins in the immune system. Curr Drug Targets. 2006;7:1011-1020. (Pubitemid 44227584)
15. Luger TA, Lotti T. Neuropeptides: role in inflammatory skin diseases. J Eur Acad Dermatol Venereol. 1998;10:207-211. (Pubitemid 28238505)
16. McClellan SA, Zhang Y, Barrett RP, et al. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: antiinflammatory mediators downregulated. Invest Ophthalmol Vis Sci. 2008; 49:1502-1511.
17. Szliter EA, Lighvani S, Barrett RP, et al. Vasoactive intestinal peptide balances pro- and anti-inflammatory cytokines in the Pseudomonas aeruginosa-infected cornea and protects against corneal perforation. J Immunol. 2007;178:1105-1114. (Pubitemid 46098857)
18. Lucey DR, Novak JM, Polonis VR, et al. Characterization of substance P binding to human monocytes/macrophages. Clin Diagn Lab Immunol. 1994;1:330-335. (Pubitemid 2085429)
19. Payan DG. Neuropeptides and inflammation: the role of substance P. Annu Rev Med. 1989;40:341-352. (Pubitemid 19145362)
20. Chauhan VS, Kluttz JM, Bost KL, et al. Prophylactic and therapeutic targeting of the neurokinin-1 receptor limits neuroinflammation in a murine model of pneumococcal meningitis. J Immunol. 2011;186:7255-7263.
21. Sahbaie P, Shi X, Guo TZ, et al. Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision. Pain. 2009;145:341-349.
22. Sun J, Ramnath RD, Zhi L, et al. Substance P enhances NF-kappaB transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathways. Am J Physiol Cell Physiol. 2008;294:C1586-C1596.
23. Hong HS, Lee J, Lee E, et al. A new role of substance P as an injuryinducible messenger for mobilization of CD29(+) stromal-like cells. Nat Med. 2009;15:425-435.
24. Delgado AV, McManus AT, Chambers JP. Exogenous administration of substance P enhances wound healing in a novel skin-injury model. Exp Biol Med (Maywood). 2005;230:271-280. (Pubitemid 40478252)
25. Muangman P, Tamura RN, Muffley LA, et al. Substance P enhances wound closure in nitric oxide synthase knockout mice. J Surg Res. 2009;153:201-209.
26. Zhou Z, Barrett RP, McClellan SA, et al. Substance P delays apoptosis, enhancing keratitis after Pseudomonas aeruginosa infection. Invest Ophthalmol Vis Sci. 2008;49:4458-4467.
27. Hazlett LD, McClellan SA, Barrett RP, et al. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection. Invest Ophthalmol Vis Sci. 2007;48:797-807. (Pubitemid 351260715)
28. Carrington LM, Boulton M. Hepatocyte growth factor and keratinocyte growth factor regulation of epithelial and stromal corneal wound healing. J Cataract Refract Surg. 2005;31:412-423. (Pubitemid 40379653)
29. Repertinger SK, Campagnaro E, Fuhrman J, et al. EGFR enhances early healing after cutaneous incisional wounding. J Invest Dermatol. 2004; 123:982-989. (Pubitemid 39391946)
30. Wilson SE, Chen L, Mohan RR, et al. Expression of HGF, KGF, EGF and receptor messenger RNAs following corneal epithelial wounding. Exp Eye Res. 1999;68:377-397. (Pubitemid 29185432)
31. Jiang X, McClellan SA, Barrett RP, et al. VIP and growth factors in the infected cornea. Invest Ophthalmol Vis Sci. 2011;52:6154-6161.
32. Hazlett LD, Moon MM, Strejc M, et al. Evidence for N-acetylmannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea. Invest Ophthalmol Vis Sci. 1987;28:1978-1985. (Pubitemid 18019956)
33. Pedchenko VK, Imagawa W. Estrogen treatment in vivo increases keratinocyte growth factor expression in the mammary gland. J Endocrinol. 2000;165:39-49. (Pubitemid 30210564)
34. Sensoo T, Joyce NC. Cell cycle kinetics in corneal endothelium from old and young donors. Invest Ophthalmol Vis Sci. 2000;41:660-667. (Pubitemid 30158873)
35. Fortier AH. Isolation of murine macrophages. In: Coligan JE, Bierer BE, Margulies DH, et al, eds. Current Protocols in Immunology. New York: John Wiley and Sons; 1994: 1411.11-14.11.16.
36. Bowden JJ, Garland AM, Baluk P, et al. Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation. Proc Natl Acad Sci U S A. 1994;91:8964-8968.
37. Jing C, Jia-Han W, Hong-Xing Z. Double-edged effects of neuropeptide substance P on repair of cutaneous trauma. Wound Repair Regen. 2009; 18:319-324.
38. Wilson SE, Mohan RR, Mohan RR, et al. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res. 2001;20:625-637. (Pubitemid 32695343)
39. Klenkler B, Sheardown H. Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology. Exp Eye Res. 2004;79:677-688. (Pubitemid 39410370)
40. Edwards JP, Zhang X, Mosser DM. The expression of heparin-binding epidermal growth factor-like growth factor by regulatory macrophages. J Immunol. 2009;182:1929-1939.
41. Imanishi J, Kamiyama K, Iguchi I, et al. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. 2000;19:113-129.
42. Kohara H, Tajima S, Yamamoto M, et al. Angiogenesis induced by controlled release of neuropeptide substance P. Biomaterials. 2010;31: 8617-8625.
43. Ziche M, Morbidelli L, Pacini M, et al. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res. 1990;40:264-278. (Pubitemid 20327679)
44. Nakamura M, Ofuji K, Chikama T, et al. Combined effects of substance P and insulin-like growth factor-1 on corneal epithelial wound closure of rabbit in vivo. Curr Eye Res. 1997;16:275-278. (Pubitemid 27129973)
45. Lai X, Wang Z, Wei L, et al. Effect of substance P released from peripheral nerve ending on endogenous expression of epidermal growth factor and its receptor in wound healing. Chin J Traumatol. 2002;5: 176-179. (Pubitemid 43020546)
46. Wilson SE, He YG, Weng J, et al. Effect of epidermal growth factor, hepatocyte growth factor, and keratinocyte growth factor on proliferation, motility and differentiation of human corneal epithelial cells. Exp Eye Res. 1994;59:665-678.
47. Zelenka PS, Arpitha P. Coordinating cell proliferation and migration in the lens and cornea. Semin Cell Dev Biol. 2008;19:113-124. (Pubitemid 351258370)
48. Li-juan B, Bing L, Zhi L, et al. Hepatocyte growth factor suppresses tumor cell apoptosis in nasopharyngeal carcinoma by upregulating Bcl-2 protein expression. Pathol Res Pract. 2009;205:828-837.
49. Wilson SE, Walker JW, Chwang EL, et al. Hepatocyte growth factor, keratinocyte growth factor, their receptors, FGF receptor-2, and the cells of the cornea. Invest Ophthalmol Vis Sci. 1993;34:2544-2561. (Pubitemid 23206485)
50. Matsumoto K, Hashimoto K, Yoshikawa K. Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor. Exp Cell Res. 1991;196:114-120. (Pubitemid 121006377)
51. Sotozono C, Kinoshita S, Kita M, et al. Paracrine role of keratinocyte growth factor in rabbit corneal epithelial cell growth. Exp Eye Res. 1994; 59:385-391. (Pubitemid 24352071)
52. Marchese C, Rubin J, Ron D, et al. Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J Cell Physiol. 1990;144:326-332.
53. Sotozono C, Inatomi T, Nakamura M, et al. Keratinocyte growth factor accelerates corneal epithelial wound healing in vivo. Invest Ophthalmol Vis Sci. 1995;36:1524-1529.
54. Huo Y, Qui WY, Pan Q, et al. Reactive oxygen species (ROS) are essential mediators in epidermal growth factor (EGF)-stimulated corneal epithelial cell proliferation, adhesion, migration, and wound healing. Exp Eye Res. 2009;89:876-886.
55. Guilbert L, Robertson SA, Wegmann TG. The trophoblast as an integral component of a macrophage-cytokine network. Immunol Cell Biol. 1993; 71(pt 1):49-57. (Pubitemid 23038700)
56. Muñoz M, Rosso M, Aguilar FJ, et al. NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2. Invest New Drugs. 2008;26:111-118.
57. Zhou Z, Wu M, Barrett RP, et al. Role of the Fas pathway in Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci. 2010;51: 2537-2547.
58. Li DQ, Tseng SC. Differential regulation of keratinocyte growth factor and hepatocyte growth factor/scatter factor by different cytokines in human corneal and limbal fibroblasts. J Cell Physiol. 1997;172:361-372. (Pubitemid 27376202)
59. Yamada N, Matsuda R, Morishige N, et al. Open clinical study of eyedrops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy. Br J Ophthalmol. 2008;92: 896-900. (Pubitemid 351969664)